Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate
Year: 2007
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Bone
Language: English
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Novartis, Novartis Pharma
OpenAlex ID: W2108258946
